Dr. Carmen Julia Calfa shares a life-saving case of personalized cancer treatment – Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared the following post on LinkedIn:
“Dr. Carmen Julia Calfa met one of her patients at a challenging point in her breast cancer journey—she had been advised to focus on symptom management and consider hospice care, as her tumor had never been sequenced. Fortunately, after genomic testing, molecular alterations were found that qualified her for immunotherapy under the American Society of Clinical Oncology (ASCO) TAPUR trial. Remarkably, she has been cancer-free for four and a half years since then.
‘She’s not the only one, but that’s likely one life saved right there,’ says Dr. Calfa. ‘We wish we could see patients like her earlier. You don’t have to wait until nothing else is working to do this analysis and give personalized treatment.’
Discover how germline testing can provide valuable insights into the most appropriate screening and treatment regimen for you.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023